Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk | Science Translational Medicine

Skip to main content

Article Information

vol. 4 no. 134 134ps11

DOI:

https://doi.org/10.1126/scitranslmed.3003572

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

Copyright & Usage:

Copyright © 2012, American Association for the Advancement of Science

Author Information

Werner Scheuer¹,
Gooitzen M. van Dam²,
Michael Dobosz¹,
Markus Schwaiger³ and
Vasilis Ntziachristos⁴,*

¹Oncology Research, Roche Diagnostics GmbH, Penzberg 82377, Germany.
²University Medical Center Groningen, Department of Surgery, Groningen 9700 RB Groningen, Netherlands.
³Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München 81675, Germany.
⁴Biological and Medical Imaging, Technische Universität München and Helmholtz Zentrum, München, 81675, Germany.

↵*Corresponding author. E-mail: v.ntziachristos{at}tum.de

Altmetric

Article usage

Article usage: May 2012 to April 2019

	Abstract	Full	Pdf
May 2012	3850	155	184
Jun 2012	578	36	51
Jul 2012	309	18	33
Aug 2012	214	6	18
Sep 2012	143	5	26
Oct 2012	196	12	13
Nov 2012	191	10	15
Dec 2012	96	3	7
Jan 2013	136	8	14
Feb 2013	92	4	7
Mar 2013	74	6	13
Apr 2013	87	8	11
May 2013	100	0	7
Jun 2013	101	3	6
Jul 2013	65	3	7
Aug 2013	63	5	7
Sep 2013	82	3	7
Oct 2013	72	4	10
Nov 2013	73	6	12
Dec 2013	83	3	12
Jan 2014	73	9	16
Feb 2014	67	4	9
Mar 2014	40	5	13
Apr 2014	84	2	12
May 2014	81	2	8
Jun 2014	69	9	10
Jul 2014	77	4	11
Aug 2014	60	2	9
Sep 2014	39	1	8
Oct 2014	63	5	21
Nov 2014	44	6	6
Dec 2014	37	2	7
Jan 2015	37	2	6
Feb 2015	52	3	8
Mar 2015	45	2	6
Apr 2015	33	3	5
May 2015	46	1	2
Jun 2015	45	4	9
Jul 2015	30	0	2
Aug 2015	56	2	3
Sep 2015	22	0	0
Oct 2015	36	2	4
Nov 2015	21	3	3
Dec 2015	42	3	6
Jan 2016	52	5	13
Feb 2016	38	4	3
Mar 2016	36	5	9
Apr 2016	32	2	6
May 2016	34	4	7
Jun 2016	39	2	2
Jul 2016	44	4	1
Aug 2016	55	4	2
Sep 2016	48	3	1
Oct 2016	44	3	1
Nov 2016	50	2	3
Dec 2016	53	4	0
Jan 2017	37	3	6
Feb 2017	30	3	0
Mar 2017	41	0	4
Apr 2017	44	0	3
May 2017	29	3	4
Jun 2017	41	0	2
Jul 2017	33	2	1
Aug 2017	45	1	0
Sep 2017	48	5	5
Oct 2017	30	3	1
Nov 2017	54	4	2
Dec 2017	32	1	4
Jan 2018	26	1	1
Feb 2018	25	2	1
Mar 2018	30	5	4
Apr 2018	49	3	2
May 2018	54	2	2
Jun 2018	54	3	4
Jul 2018	32	5	1
Aug 2018	32	4	3
Sep 2018	45	3	3
Oct 2018	53	4	0
Nov 2018	36	9	1
Dec 2018	39	6	2
Jan 2019	29	4	4
Feb 2019	39	4	1
Mar 2019	27	6	4
Apr 2019	11	3	2

Science Translational Medicine: 4 (134)

Science Translational Medicine

Vol 4, Issue 134
16 May 2012

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message
Download Powerpoint
Print
Save to my folders

Log In with your AAAS Login
Alerts

Please log in to add an alert for this article.

Log In with your AAAS Login

Sign In to Email Alerts with your Email Address
Email
Citation tools
Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk

By Werner Scheuer, Gooitzen M. van Dam, Michael Dobosz, Markus Schwaiger, Vasilis Ntziachristos

Science Translational Medicine16 May 2012 : 134ps11

Using drugs as optical imaging agents and “microdosing” amounts reduces risk for clinical translation of fluorescence molecular imaging.

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share

Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk

By Werner Scheuer, Gooitzen M. van Dam, Michael Dobosz, Markus Schwaiger, Vasilis Ntziachristos

Science Translational Medicine16 May 2012 : 134ps11

Using drugs as optical imaging agents and “microdosing” amounts reduces risk for clinical translation of fluorescence molecular imaging.

Share This Article:

Citing Articles in: